Economic burden associated with multi-resistant Gram-negative organisms compared with that for methicillin-resistant Staphylococcus aureus in a university teaching hospital

This publication has 8 references indexed in Scilit:

• Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital
  American Journal of Infection Control, 2004
• Detailed cost analysis of care for survivors of severe sepsis
  Critical Care Medicine, 2004
• Economics of Preventing Hospital Infection
  Emerging Infectious Diseases, 2004
• The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
  Annals of Internal Medicine, 2002
• Impact of antibiotic resistance on clinical outcomes and the cost of care
  Critical Care Medicine, 2001
• The Economic Impact of Methicillin-Resistant Staphylococcus aureus in Canadian Hospitals
  Infection Control & Hospital Epidemiology, 2001
• Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci
  Journal of Antimicrobial Chemotherapy, 1999
• Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital.
  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1999